American Heart Association says new reversible drug shows early promise in preventing dangerous Clots
December 22, 2015
American Heart Association Rapid Access Journal Report
Dallas, TX – A new drug that protects against dangerous blood clots in patients undergoing procedures such as angioplasty to restore blood flow through the coronary arteries, appears safe, fast, and the effects are uniquely reversible, according to early testing described in the American Heart Association journal: Arteriosclerosis, Thrombosis and Vascular Biology.
Antiplatelet drugs currently available to patients carry an increased risk of bleeding.
A uniquely acting antiplatelet agent, PZ-128, appears to be safe and fast for preventing blood clots and its effects are reversible, reducing risk for excessive bleeding. (American Heart Association)
